Epigenetic Modifications as Therapeutic Targets
Curr Drug Targets
.
2020;21(11):1046.
doi: 10.2174/138945012111200727122724.
Authors
Yi-Chao Zheng
1
,
Si-Qi Feng
1
Affiliation
1
School of Pharmaceutical Sciences Zhengzhou University Zhengzhou, China.
PMID:
32951568
DOI:
10.2174/138945012111200727122724
No abstract available
Publication types
Editorial
MeSH terms
Antineoplastic Agents / therapeutic use
Drug Approval
Epigenesis, Genetic / drug effects*
Humans
Neoplasms / drug therapy*
Neoplasms / genetics*
Substances
Antineoplastic Agents